Back
Eventbrite Vs. Aligos Therapeutics Industry Stock Comparison
Sell
41
EB
Eventbrite
Last Price:
$3.51
Seasonality Move:
-17.14%
Sell
42
ALGS
Aligos Therapeutics
Last Price:
$32.13
Seasonality Move:
-27%
Sell
41
Eventbrite (EB)
is a Sell
Is Eventbrite a Buy, Sell or Hold?
-
The current Eventbrite [EB] share price is $3.40. The Score for EB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
EB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $32.86. The Score for ALGS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EB Stock Price Chart
What is Eventbrite's stock price today?
-
The Eventbrite share price today is $3.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EB is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $32.86The current trend is moderately bearish and ALGS is experiencing slight selling pressure.
EB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 46.07 | Sell |
Chaikin Money Flow: | -414637 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.36 - 3.58) | Sell |
Bollinger Bands (100): | (2.92 - 3.6) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.5 | Buy |
Relative Strength Index (14 RSI): | 47.49 | Sell |
Chaikin Money Flow: | -47792 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.89 - 41.25) | Sell |
Bollinger Bands (100): | (7.86 - 31.76) | Buy |
EB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.43 | Sell |
20-day SMA: | 3.45 | Sell |
50-day SMA: | 3.56 | Sell |
200-day SMA: | 4.05 | Sell |
8-day EMA: | 3.46 | Sell |
20-day EMA: | 3.48 | Sell |
50-day EMA: | 3.47 | Sell |
200-day EMA: | 4.26 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.79 | Buy |
20-day SMA: | 37.67 | Sell |
50-day SMA: | 29.7 | Buy |
200-day SMA: | 17.56 | Buy |
8-day EMA: | 33.96 | Sell |
20-day EMA: | 34.87 | Sell |
50-day EMA: | 30.06 | Buy |
200-day EMA: | 20.88 | Buy |
Eventbrite Earnings Growth & EB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.09 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Eventbrite Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |